期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (3)
Background Infantile myofibromatosis (IM) is a rare benign soft tissue tumor and often a self-limiting disease but rarely includes life-threatening co......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (1)
Multiple factors can facilitate or impede the fulfillment of communication functions in pediatric cancer. In this systematic review, we evaluated 109 ......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (4)
Background/objectives Wilms tumor (WT) is a curable type of cancer with 5-year survival rates of over 90% in high-income countries, whereas this is le......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (7)
Background Socioeconomic differences in survival among children with acute lymphoblastic leukemia (ALL) have been reported in high-income countries an......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (8)
Background Disparities in end-of-life (EOL) care for children with cancer remain understudied. We addressed this gap by examining patterns of EOL care......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (7)
Background Pneumatosis intestinalis (PI) is characterized by the presence of intramural gas in the gastrointestinal (GI) tract. The overall aim of thi......
期刊： PEDIATRIC BLOOD & CANCER, 2022; 69 (3)
Background Neuroblastoma is the most common extracranial solid tumor in children. Those with high-risk disease are treated with multimodal therapy, in......
